高危乳腺癌的临床试验
总计2441个结果
-
Taipei City Hospital完全的PRU(血小板反应单位) | APT(抗血小板治疗) | HOTPR(High on Treat Platelet Reactivity)台湾
-
Dana-Farber Cancer InstituteEli Lilly and Company招聘中
-
University Medical Center Groningen终止
-
University of Illinois at ChicagoNational Cancer Institute (NCI)招聘中
-
New York City Health and Hospitals CorporationNew York State Department of Health完全的
-
Array BioPharma完全的反洗钱 | 晚期和选定的实体瘤 | 高风险和极高风险 MDS美国, 澳大利亚, 意大利, 西班牙, 法国, 瑞士, 英国
-
George Washington UniversityUniversity of North Carolina, Chapel Hill; Aga Khan University; Kenya Medical Research Institute; Christian Medical College, Vellore, India 和其他合作者招聘中
-
London School of Hygiene and Tropical MedicineRawalpindi Medical College完全的
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Illinois... 和其他合作者完全的
-
University of British ColumbiaNational Institutes of Health (NIH)完全的
-
National Cancer Institute (NCI)Cancer and Leukemia Group B完全的乳腺癌 | 高风险 | 环磷酰胺 | 正节点 | 阿霉素美国
-
Oregon Health and Science UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
University of Texas Southwestern Medical Center完全的
-
Mount Sinai Hospital, CanadaOntario Mental Health Foundation未知
-
VIVE - The Danish Center for Social Science ResearchYale University; Metodecentret - Center for Effective Innovation in Social Services招聘中
-
The University of Texas Health Science Center,...Merck Sharp & Dohme LLC主动,不招人
-
Università Politecnica delle Marche完全的
-
Centre Hospitalier Universitaire de Saint Etienne终止
-
Gustave Roussy, Cancer Campus, Grand Paris完全的
-
Jiangsu HengRui Medicine Co., Ltd.邀请报名
-
Abbott Medical Devices完全的